[go: up one dir, main page]

MX9709013A - Forma de dosis que comprende oxibutinina. - Google Patents

Forma de dosis que comprende oxibutinina.

Info

Publication number
MX9709013A
MX9709013A MX9709013A MX9709013A MX9709013A MX 9709013 A MX9709013 A MX 9709013A MX 9709013 A MX9709013 A MX 9709013A MX 9709013 A MX9709013 A MX 9709013A MX 9709013 A MX9709013 A MX 9709013A
Authority
MX
Mexico
Prior art keywords
oxybutynin
dosage form
composition
disclosed
therapy
Prior art date
Application number
MX9709013A
Other languages
English (en)
Other versions
MXPA97009013A (es
Inventor
George V Guittard
Francisco Jao
Susan M Marks
David J Kidney
Fernando Gumucio
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23770440&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9709013(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9709013A publication Critical patent/MX9709013A/es
Publication of MXPA97009013A publication Critical patent/MXPA97009013A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una composicion que comprende oxibutina y un dispositivo que comprende la misma para terapia con oxibutinina.
MXPA/A/1997/009013A 1995-05-22 1997-11-21 Forma de dosis que comprende oxibutinina MXPA97009013A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/445,849 US5674895A (en) 1995-05-22 1995-05-22 Dosage form comprising oxybutynin
US08445849 1995-05-22
PCT/US1996/006639 WO1996037202A1 (en) 1995-05-22 1996-05-08 Dosage form comprising oxybutynin

Publications (2)

Publication Number Publication Date
MX9709013A true MX9709013A (es) 1998-03-31
MXPA97009013A MXPA97009013A (es) 1998-10-15

Family

ID=

Also Published As

Publication number Publication date
DE19681389B3 (de) 2015-12-10
AU695194B2 (en) 1998-08-06
US5840754A (en) 1998-11-24
AU5639296A (en) 1996-12-11
IT1285345B1 (it) 1998-06-03
CA2510391A1 (en) 1996-11-28
JP2007197462A (ja) 2007-08-09
ITTO960427A0 (it) 1996-05-21
FR2734483B1 (fr) 1997-07-11
GB2318055B (en) 1999-07-21
ITTO960427A1 (it) 1997-11-21
AU9052298A (en) 1999-01-14
GB9723081D0 (en) 1998-01-07
JPH11505264A (ja) 1999-05-18
AU718849B2 (en) 2000-04-20
BE1009462A3 (fr) 1997-04-01
NL1003185A1 (nl) 1996-11-25
WO1996037202A1 (en) 1996-11-28
CA2218714A1 (en) 1996-11-28
US5674895A (en) 1997-10-07
NL1003185C2 (nl) 1996-12-03
GB2318055A (en) 1998-04-15
DE19681389T1 (de) 1998-04-23
NZ307116A (en) 1999-03-29
KR19990021879A (ko) 1999-03-25
CA2218714C (en) 2005-08-23
FR2734483A1 (fr) 1996-11-29
KR100404954B1 (ko) 2004-04-28
CH690955A5 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
GB2318055A (en) Dosage form comprising oxybutynin
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
ZA9610729B (en) Transdermal device for the delivery of flurbiprofen.
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
IL114162A0 (en) Submersive therapy apparatus
EP0759306A3 (en) Device for administering medication
ZA967502B (en) Medicament delivery device.
HUP9802983A3 (en) Composition for transdermal delivery
AU7961094A (en) Picosulphate dosage form
AU2148095A (en) Fuel treatment device
AU6239796A (en) Apparatus for relieving back pain
AUPM695294A0 (en) Improved combination therapy dose unit
ZA964373B (en) A pharmaceutical composition for treating lukemia
GB9509572D0 (en) Cancer therapy
GB9506512D0 (en) Electro-magnetic therapy device
EP0839032A4 (en) HYDROXYL IONS AS SPECIAL THERAPEUTIC AGENTS, AND COMPOUNDS SUITABLE TO MODULATE THESE IONS, COMPOUNDS
EP0868430A4 (en) THERAPEUTIC COMPOSITIONS
GB9524942D0 (en) Drug therapy
GB9511831D0 (en) Fuel treatment device
ES2141044A1 (es) Terapia con oxibutinina.
GB9409235D0 (en) Transdermal dosage form
GB9409289D0 (en) Transdermal dosage form
AU9075091A (en) Device for providing therapy for muscles
JO1710B1 (en) Therapeutic agents
GB9409824D0 (en) Dosage form